710151-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001459 -USTECINUMAB 45 MG SOL INJ

World Biggest Tenders Source

This tender with title 710151-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001459 -USTECINUMAB 45 MG SOL INJ -- Contract Value: 321 280,00 EUR has been published on Bidding Source portal dated 30 Oct 2025 for the country of Portugal. It has been categorized on Antineoplastic and immunomodulating agents. For similar tenders you can see tenders mentioned below of this page.

Contract Value: 321 280,00 EUR

General Information

Portugal

Tender Title :

710151-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001459 -USTECINUMAB 45 MG SOL INJ
Contract Value: 321 280,00 EUR

Tender Type :

Contract Award

Reference No. :

710151

Country :

Portugal

Publish Date :

30 Oct 2025

Notice Language :

English

Tender Categories (CPVs) :

Antineoplastic and immunomodulating agents

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

832865-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DARATUMUMAB [120 MG/ ML 15 ML SOL INJ FRS] Portugal 832999-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal 833162-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal 833239-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491- RUXOLITINIB [20 MG CÁP/COMP] Portugal 833767-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491- RUXOLITINIB [20 MG CÁP/COMP] Portugal 834391-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA] Portugal 834437-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491- RUXOLITINIB [20 MG CÁP/COMP] Portugal 834947-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - DUPILUMAB [300 MG/ 2 ML SOL INJ CANETA] Portugal 836708-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal 836717-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - DUPILUMAB [300 MG/ 2 ML SOL INJ CANETA] Portugal

710151-Awarded - Portugal – Antineoplastic and immunomodulating agents – 251G001459 -USTECINUMAB 45 MG SOL INJ

Contract Value: 321 280,00 EUR

General Information

Portugal

Similar Tenders

Antineoplastic and immunomodulating agents Tenders

Portugal Tenders

Europe Tenders

Tenders

info@biddingsource.com